Bearish flow noted in Recursion Pharmaceuticals with 1,044 puts trading, or 2x expected. Most active are Sep-24 12 puts and Aug-24 10 calls, with total volume in those strikes near 930 contracts. The Put/Call Ratio is 1.92, while ATM IV is up over 1 point on the day. Earnings are expected on August 6th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals price target lowered to $12 from $16 at KeyBanc
- Cathie Wood’s ARK Investment bought 143K shares of Recursion Pharmaceuticals
- Cathie Wood’s ARK Investment bought 423K shares of Recursion Pharmaceuticals
- AI Could Revolutionize Drug Discovery: A Look at Key Players
- Cathie Wood’s ARK Investment bought 505K shares of Recursion Pharmaceuticals